Tenax Therapeutics Announces Second Quarter 2016 Financial Results And Provides Corporate Update
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today announced financial results for the second quarter ended June 30, 2016, and provided a corporate update.